To cite this paper use one of the standards below:
Introduction: YEG mAb Sc-G1 (G1) is a monoclonal antibody generated using the structure-based prion vaccine 14R1. Recognizing a native, discontinuous epitope on a β-solenoid fold, it fails to bind PrPSc in its PIRIBS structure, as epitope residues would be spatially separated. Although, all recent ex-vivo high-resolution structures of PrPSc show a PIRIBS conformation, antibody G1 raises the possibility of alternative infectious prion conformers.
Objectives: To isolate the putative β-solenoid variant of PrPSc from infected RML brain homogenates using Fab G1 and determine their infectivity using bioassays.
Methods: Brain homogenates from RML-infected mice were immunoprecipitated using Protein-L beads coupled with Fab G1. Following incubation and washes, the complex of PrPSc-Fab G1 was eluted and collected pulldown fractions were inoculated intracerebrally into FVB mice. Experiments were performed in triplicates, including a set of controls with a non-PrP binding Fab (anti-HER2). Mice were monitored for clinical signs of prion disease.
Results and Discussion: Fab G1 immunoprecipitated a β-solenoid variant of PrPSc showing partial PK-resistance. Inoculation with G1-eluates produced clinical symptoms and incubation periods comparable to those of 1% brain homogenate controls. In contrast, mice inoculated with HER2-eluates have not developed clinical symptoms to date. These results suggest that G1 captures a subset of infectious PrPSc conformers consistent with a β-solenoid fold that are distinct from the widely accepted PIRIBS conformations of PrPSc.
Conclusion: The findings support the concept of structural heterogeneity, with at least two distinct conformers in the same brain tissue sample, highlighting the utility of conformation-specific antibodies in prion disease research.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper